T. Rowe Price Investment Management, Inc. - GENERATION BIO CO ownership

GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of GENERATION BIO CO
ValueSharesWeighting
Q3 2023$13,309
-31.1%
3,511,4560.0%0.01%
-30.8%
Q2 2023$19,314
+32.8%
3,511,456
+3.9%
0.01%
+30.0%
Q1 2023$14,539
+3.4%
3,380,956
-5.5%
0.01%
-9.1%
Q4 2022$14,061
-99.9%
3,577,755
+2.7%
0.01%
-26.7%
Q3 2022$18,493,0003,482,6170.02%
Other shareholders
GENERATION BIO CO shareholders Q4 2022
NameSharesValueWeighting ↓
Trustees of Columbia University in the City of New York 312,876$8,870,00011.85%
Foresite Capital Management IV, LLC 857,939$24,323,0002.64%
Artal Group S.A. 2,814,191$79,782,0001.71%
Darwin Global Management, Ltd. 197,191$5,590,0001.56%
Casdin Capital, LLC 1,611,214$45,678,0001.35%
Penn Mutual Asset Management 40,545$1,149,0001.02%
HARVARD MANAGEMENT CO INC 521,460$14,783,0000.80%
Bellevue Group AG 2,333,180$66,146,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 961,215$27,250,0000.54%
FARALLON CAPITAL MANAGEMENT LLC 2,268,819$64,321,0000.39%
View complete list of GENERATION BIO CO shareholders